Key statistics
As of last trade, 10X Genomics Inc (TXG:NSQ) traded at 14.92, 15.17% above the 52 week low of 12.95 set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.70 |
---|---|
High | 15.67 |
Low | 14.61 |
Bid | 14.91 |
Offer | 14.92 |
Previous close | 14.31 |
Average volume | 2.51m |
---|---|
Shares outstanding | 121.05m |
Free float | 103.97m |
P/E (TTM) | -- |
Market cap | 1.73bn USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 19:42 GMT.
More ▼
- 10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
- TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
- 10x Genomics Reports Third Quarter 2024 Financial Results
- 10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches
- 10x Genomics Announces Preliminary Select Third Quarter 2024 Results
- 10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
- Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
- 10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
More ▼